Skip to main content

Enuresis und funktionelle Harninkontinenz

  • Chapter
  • First Online:
Neuro-/Psychopharmaka im Kindes- und Jugendalter
  • 2471 Accesses

Zusammenfassung

Enuresis nocturna wird als Einnässen im Schlaf, funktionelle Harninkontinenz als Einnässen tags ab einem Alter von 5 Jahren nach Ausschluss organischer Ursachen definiert. Viele verschiedene Subtypen können differenziert werden. Eine genaue Diagnostik ist für eine spezifische, wirksame Therapie entscheidend. Für alle Formen der Enuresis nocturna und der funktionellen Harninkontinenz sind symptomorientierte, nichtpharmakologische Interventionen wegen der besseren Wirksamkeit zu bevorzugen. Eine Indikation zur Pharmakotherapie ergibt sich nur bei der Enuresis nocturna (vor allem mit Desmopressin), bei der Dranginkontinenz (Anticholinergika) und in den seltenen Fällen der Lachinkontinenz (Psychostimulanzien). Komorbide psychische Störungen, die 20–40 % der Kinder mit Enuresis und/oder Harninkontinenz betreffen, sind zu beachten.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 149.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Alloussi S, Mürtz G, Braun R et al. (2009) Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxbutinine in children with urge incontinence due to overactive bladder: results of a multicentre observational cohort study. BJU Int 106:550–556

    Article  PubMed  Google Scholar 

  • Austin P, Bauer S, Bower W et al. (2016) The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the international children’s continence society (ICCS). Neurourol Urodyn 35:471–481

    Article  PubMed  Google Scholar 

  • Barroso U, Tourinho R, Lordelo P, Hoebeke P, Chase J (2011) Electrical stimulation for lower urinary tract dysfunction in children: a systematic review of the literature. Neurolurol Urodynam 30:1429–1436

    Article  Google Scholar 

  • Berry AK, Zderik S, Carr M (2009) Methylphenidate for giggle incontinence. J Urol 182(4 Suppl):2028–2032

    Article  CAS  PubMed  Google Scholar 

  • Biederman J, Thisted RA, Greenhill LL, Ryan ND (1995) Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children. J Clin Psychiatry 56:87–93

    CAS  PubMed  Google Scholar 

  • Blais AS, Nadeau G, Moore K, Genois L, Bolduc S (2016) Prosepctive pilot study of mirabegron in pediatric patients with overactive bladder. Eur Urol 70:9–13

    Article  PubMed  Google Scholar 

  • Bolduc S, Moore K, Nadeau G et al. (2010) Prospective open label study of solifenacin for overactive bladder in children. J Urol 184(4 Suppl):1668–1673

    Article  PubMed  Google Scholar 

  • Caldwell PHY, Nankivell G, Sureshkumar P (2013) Simple behavioural interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 7:Art No CD003637. https://doi.org/10.1002/14651858.CD003637.pub3

    Article  Google Scholar 

  • Caldwell PHY, Sureshkumar P, Wong WCF (2016) Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev 1:Art No CD002117. https://doi.org/10.1002/14651858.CD002117.pub2

    Article  Google Scholar 

  • Caldwell PHY, Codarini M, Stewart F, Hahn D, Sureshkumar P (2020) Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 5:Art No CD002911. https://doi.org/10.1002/14651858.CD002911.pub3

    Article  PubMed  Google Scholar 

  • Chang JH, Lee KY, Kim TB et al. (2011) Clinical and urodynamic effect of methylphenidate for the treatment of giggle incontinence. Neurourol Urodynam 30:1338–1342

    Article  CAS  Google Scholar 

  • Claßen M, von Gontard A et al (2021) S2k-Leitlinie Funktionelle (nicht-organische) Obstipation und Stuhlinkontinenz im Kindes- und Jugendalter (AWMF Registernummer 068-019) (AWMF-online)

    Google Scholar 

  • De Bruyne P, De Guchtenare A, Van Herzeele Ch et al. (2014) Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis. Eur J Pediatr 173:223–228

    Article  PubMed  Google Scholar 

  • Deshpande AV, Caldwell PHY, Sureshkumar P (2012) Drugs for nocturnal enuresis in childrten (other than desmopressin). Cochrane Database Syst Rev 12:Art No CD002238. https://doi.org/10.1002/14651858.CD002238.pub2

    Article  PubMed  Google Scholar 

  • Equit M, Sambach H, Niemczyk J, von Gontard A (2013) Ausscheidungsstörungen bei Kindern und Jugendlichen – ein Therapieprogramm zur Blasen- und Darmschulung. Hogrefe, Göttingen

    Google Scholar 

  • Falkai P, Wittchen H-U (2015) American Psychiatric Association. Diagnostisches und Statistisches Manual Psychischer Störungen DSM-5. Hogrefe, Göttingen

    Google Scholar 

  • Fernandes L, Martin D, Hum S (2018) A case of the giggles: diagnosis and management of giggle incontinence. Can Fam Physician 64:445–447

    PubMed  PubMed Central  Google Scholar 

  • Ferring (2011) Fachinformation Minirin Lyophilisat. Rote Liste Service GmbH, Fachinfoservice, Berlin

    Google Scholar 

  • Franco I (2007) Overactive bladder in children. Part I: pathophysiology. J Urol 178:761–768

    Article  PubMed  Google Scholar 

  • Franco I, Austin P, Bauer S, von Gontard A, Homsy Y (ed) (2015) Pediatric incontinence: evaluation and clinical management. Wiley-Blackwell, Oxford, Hoboken

    Google Scholar 

  • Franco I, Hiebeke P, Baka-Ostrowska M et al. (2020) Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from the phase 3 prospective open-label studies. J Ped Urol 16:180.e1–180.e8

    Article  Google Scholar 

  • Gepertz S, Neveus T (2004) Imipramine for therapy resistant enuresis: a retrospective evaluation. J Urol 171:2607–2610

    Article  CAS  PubMed  Google Scholar 

  • Glazener CMA, Evans JHC (2002) Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev 3:Art No CD002112. https://doi.org/10.1002/14651858.CD002112

    Article  Google Scholar 

  • Hjälmas K, Hellström A, Mogren G, Läckgren G, Stenberg A (2001) The overactive bladder in children: a potential future indication for tolterodine. BJU Intern 87:569–574

    Article  Google Scholar 

  • Hoebeke P, De Pooter J, De Caestecker K et al. (2009) Solifenacin for therapy resistant overactive bladder. J Urol 182:2040–2044

    Article  CAS  PubMed  Google Scholar 

  • Houts AC, Berman JS, Abramson H (1994) Effectiveness of psychological and pharmalogical treatments for nocturnal enuresis. J Consult Clin Psychol 62:737–745

    Article  CAS  PubMed  Google Scholar 

  • Joinson C, Heron J, von Gontard A, the ALSPAC study team (2006) Psychological problems in children with daytime wetting. Pediatrics 118:1985–1993

    Article  PubMed  Google Scholar 

  • Juul KV, Van Herzele C, De Bruyne P et al. (2013) Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic enuresis. Eur J Pediatr 172:1235–1242

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kilic N, Balkan E, Akgoz S, Sen N, Dogruyol H (2006) Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor overactivity. Int J Urol 13:105–108

    Article  CAS  PubMed  Google Scholar 

  • Kuwertz-Bröking E, von Gontard A (2021) S2k-Leitlinie Enuresis und nicht-organische (funktionelle) Harninkontinenz bei Kindern und Jugendlichen (AWMF Registriernummer 028-026) (AWMF online)

    Google Scholar 

  • Kwak KW, Lee YS, Park KH, Baek M (2010) Efficacy of Desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study. J Urol 185:2521–2526

    Article  Google Scholar 

  • Lopez Pereira P, Miquelez C, Caffarati J, Estornell F, Anquera A (2003) Trospium chloride for the treatment of detrusor instablity in children. J Urol 170:1978–1981

    Article  CAS  PubMed  Google Scholar 

  • Lundmark E, Neveus T (2009) Reboxetine in therapy-resistant enuresis: a retrospective evaluation. Scan J Urol Nephrol 43:365–368

    Article  CAS  Google Scholar 

  • Marschall-Kehrel D, Feustel C, Persson de Geeter C et al. (2009) Treatment of propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results from a randomized placebo-controlled phase 3 clinical trial. Eur Urol 55:729–738

    Article  CAS  PubMed  Google Scholar 

  • Medhi B, Mittal N, Bansal D et al. (2013) Comparison of tolterodine with standard treatment in pediatric patients with non-neurogenic dysfunctional voiding/overactive bladder: a systematic review. Indian J Physiol Pharmacol 57:1511–1517

    Google Scholar 

  • Nevéus T, Fonseca E, Franco I et al. (2020) Management and treatment of nocturnal enuresis – an updated standardization document from the International Children’s Continence Society. J Pediatr Urol 16:10–19

    Article  PubMed  Google Scholar 

  • Neveus T, Tullus K (2008) Tolterodine and imipramine in refractory enuresis: a placebo-controlled cross-over study. Pediatr Nephrol 23:262–267

    Article  Google Scholar 

  • Newgreen D, Bosman B, Hollestein-Havelaar A et al. (2017) Solifenacin in children and adolescents with overactive bladder: results of a phase 3 randomised clinical trial. Eur Urol 71(3):483–490

    Article  CAS  PubMed  Google Scholar 

  • NICE clinical guideline 111 (2010) Nocturnal enuresis – the management of bedwetting in children and young people. National Institute for Health and Clinical Excellence, London

    Google Scholar 

  • Nieuwhof-Leppink AJ, Hussong J, Chase J et al. (2021) Definitions, indications and practice of urotherapy in children and adolescents: a standardization document of the International Children’s Continence Society (ICCS). J Pediatr Urol 17:172–181. https://doi.org/10.1016/j.jpurol.2020.11.006

    Article  PubMed  Google Scholar 

  • Nijman RJ, Borgstein NG, Ellsworth P, Djurhuss JC (2005) Tolterodine treatment for children with symptoms or urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials. J Urol 173:1334–1339

    Article  CAS  PubMed  Google Scholar 

  • Nijman RJ, Borgstein NG, Ellsworth P, Siggard C (2007) Long-term tolerability of tolterodine extended release in children 5–11 years of age: results from a 12-month, open-label study. Eur Urol 52:1511–1516

    Article  PubMed  Google Scholar 

  • Ohtomo Y (2017a) Atomoxetine ameliorates nocturnal enuresis with subclinical attention-deficit/hyperactivity disorder. Pediatr Int 59:181–184

    Article  CAS  PubMed  Google Scholar 

  • Ohtomo Y (2017b) Clonidine may have a beneficial effect on refractory nocturnal enuresis. Pediatr Int 59:711–713

    Article  CAS  PubMed  Google Scholar 

  • Rovner ES (2004) Trospium chloride in the management of overactive bladder. Drugs 64:2443–2446

    Article  Google Scholar 

  • Schäfer SK, Niemczyk J, von Gontard A et al. (2017) Standard urotherapy as first-line intervention for daytime incontinence: a meta-analysis. Eur Child Adolesc Psychiatry 27:949–964

    Article  PubMed  Google Scholar 

  • Schatzberg AF, Cole JO, DeBattista C (2003) Manual of clinical psychopharmacology. American Psychiatric Publishing, Washington

    Google Scholar 

  • Sher PK, Reinberg Y (1996) Successful treatment of giggle incontinence with methylphenidate. J Urol 156:656–658

    Article  CAS  PubMed  Google Scholar 

  • Staskin D, Kay G, Tannenbaum C et al. (2010) Trospiumchloride has no effect on memory testing and is undectable in the central nervous system of older patients with overactive bladder. Int J Clin Pract 64:1294–1300

    Article  CAS  PubMed  Google Scholar 

  • Sumner SR, Schuh KJ, Sutton VK, Lipetz R, Kelsey DK (2006) Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis. J Child Adolesc Psychopharmacol 16:699–671

    Article  PubMed  Google Scholar 

  • van Kerrebroeck PEV (2002) Experience with the long-term use of desmopressin for nocturnal enuresis in children and adolescents. BJU Int 89:420–425

    Article  PubMed  Google Scholar 

  • van Londen A, van Londen-Barensten M, van Son M, Mulder G (1995) Relapse rate and parental reaction after successful treatment of children suffering from nocturnal enuresis: a 2 ½ year follow-up of bibliotherapy. Beh Res Ther 33:309–311

    Article  Google Scholar 

  • von Gontard A (2013) The impact of DSM-5 and guidelines for assessment and treatment of elimination disorders. Eur Child Adolesc Psychiat 22(Suppl 1):S61–S67

    Article  Google Scholar 

  • von Gontard A (2014) Klassifikation der Enuresis/Enkopresis in der DSM-5. Z Kinder Jugendpsychiatr Psychother 42:109–113

    Article  Google Scholar 

  • von Gontard A (2018) Leitfaden Enuresis, 3. Aufl. Hogrefe, Göttingen

    Book  Google Scholar 

  • von Gontard A (2021) Ausscheidungsstörungen – Klassifikation und Definition nach ICD-11. Z Kinder Jugendpsychiatr Psychother 49:421–428

    Article  Google Scholar 

  • von Gontard A, Equit M (2015) Comorbidity of ADHD and incontinence in children. Eur Child Adolesc Psychiat 24:127–140

    Article  Google Scholar 

  • von Gontard A, Baeyens D, Van Hoecke E, Warzak W, Bachmann C (2011) Psychological and psychiatric issues in urinary and fecal incontinence. J Urol 185:1432–1437

    Article  Google Scholar 

  • WHO (2020) International Classification of Diseases – 11th edition (ICD-11). https://www.who.int/standards/classifications/classification-of-diseases

  • Wright A, Haddad M (2017) Electroneurostimulation for the management of bladder bowel dysfunction in childhood. Eur J Ped Neurol 21:67–74

    Article  Google Scholar 

  • Yang St, Chua ME, Bauer St et al. (2018) Diagnosis and management of bladder bowel dysfunction in children with urinary tract infections: a position statement from the International Children’s Continence Society. Ped Nephrol 33:2207–2219

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander von Gontard .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

von Gontard, A. (2023). Enuresis und funktionelle Harninkontinenz. In: Gerlach, M., Mehler-Wex, C., Romanos, M., Walitza, S., Wewetzer, C. (eds) Neuro-/Psychopharmaka im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-65267-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-65267-1_16

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-65266-4

  • Online ISBN: 978-3-662-65267-1

  • eBook Packages: Psychology (German Language)

Publish with us

Policies and ethics